These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1013787)

  • 1. [Interferon reaction of leukocytes in diffuse connective tissue diseases].
    Pitenov VA; Etkind GV; Bektemirov TA; Alekberova ZS; Barinskiĭ IF
    Sov Med; 1976 Dec; (12):21-6. PubMed ID: 1013787
    [No Abstract]   [Full Text] [Related]  

  • 2. [The spectrum of low-molecular substances in the blood serum of patients with diffuse connective tissue diseases].
    Lysenko GI; Korolev IuN
    Vrach Delo; 1986 Sep; (9):17-20. PubMed ID: 3788102
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on plasma proteins in diffuse connective tissue diseases using electrophoresis in polyacrylamide gel].
    Cebecauer L; Zitnan D
    Z Rheumaforsch; 1969; 28(5):227-31. PubMed ID: 4184267
    [No Abstract]   [Full Text] [Related]  

  • 4. Nitroblue tetrazolium dye reduction by peripheral leukocytes from rheumatoid arthritis and systemic lupus erythematosus patients measured by a histochemical and spectrophotometric method.
    Wenger ME; Bole GG
    J Lab Clin Med; 1973 Sep; 82(3):513-21. PubMed ID: 4728296
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood viscosity in rheumatic diseases].
    Nasonova VA; Balabanova RM; Loskutova TT
    Revmatologiia (Mosk); 1984; (1):22-7. PubMed ID: 6371999
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced glucose oxidation by leukocytes incubated with sera from patients with rheumatoid arthritis and systemic lupus erythematosus (SLE).
    Skosey JL; Sorensen LB
    J Lab Clin Med; 1971 Dec; 78(6):977. PubMed ID: 5131860
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduced T lymphoid colony growth in patients with progressive systemic sclerosis and rheumatoid arthritis.
    Winkelstein A; Bernstein ML; Stevens MA; Rodnan GP; Medsger TA; Dobson SA
    J Lab Clin Med; 1982 Aug; 100(2):240-7. PubMed ID: 6980249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Functional state of the blood coagulation system in patients with rheumatism and other collagenoses].
    Dashtaiants GA; Andrushchenko EV; Krasovskaia EA
    Vrach Delo; 1977 Jun; (6):32-4. PubMed ID: 302064
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in the blood protein and amino acid levels in rheumatic diseases].
    Shevel' EIa; Bagirova GG; Shevel' VA; Bagirova VV
    Ter Arkh; 1982; 54(10):87-9. PubMed ID: 7179129
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of high doses of exogenous interferon in systemic lupus erythematosus].
    Savinov VA; Alekberova ZS; Barinskiĭ IF; Bulanova TD; Kuznetsov VP
    Ter Arkh; 1981; 53(7):118-21. PubMed ID: 6170126
    [No Abstract]   [Full Text] [Related]  

  • 12. [alpha-Interferon indices in systemic lupus erythematosus and the effect of interferon therapy].
    Barinskiĭ IF; Alekberova ZS; Savinov VA; Pitenov VA; Kuznetsov VP
    Vopr Virusol; 1983; 28(6):733-6. PubMed ID: 6670258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood cholesterol level in rheumatic diseases].
    Jajić I
    Reumatizam; 1967; 14(3):91-7. PubMed ID: 6045925
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunological reactions to connective tissue antigens in rheumatoid arthritis, systemic scleroderma and systemic lupus erythematosus].
    Abdeeva ZhI; Zakharova MM; Rassokhina II; Trofimova TM; Samoĭlova SI
    Ter Arkh; 1980; 52(11):122-6. PubMed ID: 7466639
    [No Abstract]   [Full Text] [Related]  

  • 15. [Significance of low molecular physiologically active substances in autoimmune diseases].
    Lysenko GI; Korolev IuN
    Vrach Delo; 1983 Dec; (12):29-32. PubMed ID: 6670231
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prostaglandins in the pathogenesis of various systemic diseases of the connective tissue].
    Shishkin VI; Kudriavtseva GV; Makarov SA
    Ter Arkh; 1987; 59(4):67-70. PubMed ID: 3590008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective production of leucocytic endogenous mediator (interleukin 1) by peripheral blood leucocytes of patients with systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis and mixed connective tissue disease.
    Whicher JT; Gilbert AM; Westacott C; Hutton C; Dieppe PA
    Clin Exp Immunol; 1986 Jul; 65(1):80-9. PubMed ID: 3491701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon system in patients with rheumatoid arthritis and sclerodermia systematica.
    Scheglovitova ON; Balabanova RM; Kulieva AM; Seilanov LS; Anikina NV; Orlova TG
    Acta Virol; 1993 Feb; 37(1):54-60. PubMed ID: 7692710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemorheologic disturbances and circulating immune complexes in patients with rheumatic diseases].
    Loskutova TT; Koreshkov GG; Nasonov EL; Zakharchenko VN; Larionov SM
    Ter Arkh; 1989; 61(5):51-5. PubMed ID: 2781490
    [No Abstract]   [Full Text] [Related]  

  • 20. [Better characterization of antinuclear factors].
    Stojan B
    Verh Dtsch Ges Rheumatol; 1976; 4():427-32. PubMed ID: 1087085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.